Key facts
- This page summarizes Charles M. Watts's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 May 2023, 17:55.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Section 16 status
Charles M. Watts is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 69,619 RSUs, which is eleven of the twelve months.